Status:
COMPLETED
Probiotic Bacteria in Prevention of the Metabolic Syndrome
Lead Sponsor:
University Maribor
Collaborating Sponsors:
Slovenian Research Agency
Conditions:
Metabolic Syndrome X
Eligibility:
All Genders
21-85 years
Phase:
PHASE2
Brief Summary
The metabolic syndrome is increasing worldwide, including developing countries. The metabolic syndrome is composed of clinical expressed symptoms as central obesity, high blood pressure, raised fastin...
Eligibility Criteria
Inclusion
- visceral obesity and at least two of other components: raised fasting serum glucose or known diabetes type 2; raised fasting serum triglycerides; raised fasting serum cholesterol; raised fasting serum LDL and low fasting serum HDL; high blood pressure, more than 130/85 mmHg.
Exclusion
- planned invasive procedure or surgery (whole body);
- planned surgery in mouth cavity;
- weakened immune system or taking immunosuppressives;
- diagnosed inflammatory bowel disease;
- known or diagnosed lactose intolerance.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT02288572
Start Date
May 1 2013
End Date
May 1 2014
Last Update
November 11 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.